About Geneseeq
Geneseeq is a company based in Toronto (Canada) founded in 2012 by Xiaonan Wang, Yang Shao, Siming Jiang, and Marc Zhao.. Geneseeq has raised $128.44 million across 4 funding rounds from investors including Guoxin Capital, SBCVC and Langmafeng Venture Capital. The company has 6 employees as of December 31, 2024. Geneseeq operates in a competitive market with competitors including Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
- Headquarter Toronto, Canada
- Employees 6 as on 31 Dec, 2024
- Founders Xiaonan Wang, Yang Shao, Siming Jiang, Marc Zhao
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$128.44 M (USD)
in 4 rounds
-
Latest Funding Round
$114.39 M (USD), Series D
Dec 26, 2019
-
Investors
Guoxin Capital
& 5 more
-
Employee Count
6
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Geneseeq
Geneseeq has successfully raised a total of $128.44M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $114.39 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $114.4M
-
First Round
First Round
(21 Aug 2014)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series D - Geneseeq | Valuation | Guoxin Capital | |
| Jul, 2017 | Amount | Series C - Geneseeq | Valuation | Xingye Innovation Capital Management , Cowin Capital |
|
| Jun, 2016 | Amount | Series B - Geneseeq | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Geneseeq
Geneseeq has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Guoxin Capital, SBCVC and Langmafeng Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
China-based startups are invested in by SBCVC across diverse sectors.
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided to high-tech enterprises.
|
Founded Year | Domain | Location | |
|
Investments in biomedical companies are directed by Lilly Asia Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Geneseeq
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Geneseeq
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Geneseeq Comparisons
Competitors of Geneseeq
Geneseeq operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Geneseeq
Frequently Asked Questions about Geneseeq
When was Geneseeq founded?
Geneseeq was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Geneseeq located?
Geneseeq is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Is Geneseeq a funded company?
Geneseeq is a funded company, having raised a total of $128.44M across 4 funding rounds to date. The company's 1st funding round was a Series B of $9.37M, raised on Aug 21, 2014.
How many employees does Geneseeq have?
As of Dec 31, 2024, the latest employee count at Geneseeq is 6.
What does Geneseeq do?
Geneseeq was founded in 2012 in Toronto, Canada, as a health solutions provider focused on oncology. Comprehensive genomic profiling of patient RNA is conducted via next-generation sequencing techniques to inform treatment decisions. Customized RNA extraction methods have been developed for diverse sample types, including surgical sections, core needle biopsies, FFPE tissues, and low-input materials. Operations emphasize personalized care across various cancer types.
Who are the top competitors of Geneseeq?
Geneseeq's top competitors include Guardant Health, Strand Life Sciences and Juno Therapeutics.
Who are Geneseeq's investors?
Geneseeq has 6 investors. Key investors include Guoxin Capital, SBCVC, Langmafeng Venture Capital, Lilly Asia Ventures, and Xingye Innovation Capital Management.